| chromosome organization | GO:0051276 | 360 | 0.479 | |
| heterochromatin organization | GO:0070828 | 25 | 0.447 | |
| regulation of gene expression epigenetic | GO:0040029 | 128 | 0.373 | Human |
| oocyte differentiation | GO:0009994 | 145 | 0.336 | |
| dendrite development | GO:0016358 | 204 | 0.280 | |
| chromatin organization | GO:0006325 | 207 | 0.256 | |
| cell proliferation | GO:0008283 | 299 | 0.237 | |
| regulation of rna splicing | GO:0043484 | 69 | 0.235 | |
| oocyte development | GO:0048599 | 124 | 0.218 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.206 | Human |
| dna damage checkpoint | GO:0000077 | 78 | 0.188 | |
| protein dna complex assembly | GO:0065004 | 63 | 0.178 | Human |
| eye photoreceptor cell development | GO:0042462 | 81 | 0.175 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.153 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.152 | Human |
| spindle organization | GO:0007051 | 253 | 0.151 | |
| eye photoreceptor cell differentiation | GO:0001754 | 145 | 0.134 | |
| induction of programmed cell death by ecdysone | GO:0035078 | 12 | 0.125 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.124 | Human |
| macromolecular complex assembly | GO:0065003 | 256 | 0.123 | Human |
| dendrite morphogenesis | GO:0048813 | 199 | 0.122 | |
| organelle fission | GO:0048285 | 340 | 0.118 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.116 | Human |
| protein modification process | GO:0036211 | 438 | 0.111 | |
| axon guidance | GO:0007411 | 233 | 0.101 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.098 | |
| gene silencing | GO:0016458 | 138 | 0.095 | |
| oocyte construction | GO:0007308 | 112 | 0.092 | |
| nuclear division | GO:0000280 | 332 | 0.088 | |
| chromatin silencing | GO:0006342 | 76 | 0.086 | |
| regulation of cell cycle process | GO:0010564 | 181 | 0.082 | |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.078 | Human |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 73 | 0.078 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.076 | |
| head development | GO:0060322 | 135 | 0.074 | |
| mrna processing | GO:0006397 | 104 | 0.074 | |
| proteolysis | GO:0006508 | 192 | 0.074 | |
| meiosis i | GO:0007127 | 59 | 0.073 | |
| myotube cell development | GO:0014904 | 3 | 0.066 | |
| rna splicing | GO:0008380 | 83 | 0.066 | |
| body morphogenesis | GO:0010171 | 2 | 0.065 | |
| positive regulation of endopeptidase activity | GO:0010950 | 26 | 0.065 | |
| tissue morphogenesis | GO:0048729 | 297 | 0.063 | |
| regionalization | GO:0003002 | 416 | 0.063 | |
| neuron projection guidance | GO:0097485 | 241 | 0.063 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.061 | Human |
| cellular protein modification process | GO:0006464 | 438 | 0.061 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.061 | |
| stem cell development | GO:0048864 | 79 | 0.058 | |
| regulation of mrna processing | GO:0050684 | 71 | 0.058 | |
| mitotic spindle organization | GO:0007052 | 220 | 0.056 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.056 | |
| response to sterol | GO:0036314 | 34 | 0.055 | |
| cell death | GO:0008219 | 279 | 0.054 | |
| axon development | GO:0061564 | 297 | 0.054 | |
| regulation of cell division | GO:0051302 | 72 | 0.054 | |
| multicellular organismal aging | GO:0010259 | 140 | 0.053 | |
| dna conformation change | GO:0071103 | 105 | 0.053 | |
| protein ubiquitination | GO:0016567 | 70 | 0.052 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.052 | Human |
| mitotic nuclear division | GO:0007067 | 213 | 0.052 | |
| rna splicing via transesterification reactions | GO:0000375 | 73 | 0.051 | |
| histone h3 acetylation | GO:0043966 | 11 | 0.050 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.049 | Human |
| posttranscriptional regulation of gene expression | GO:0010608 | 145 | 0.048 | |
| stem cell differentiation | GO:0048863 | 117 | 0.047 | |
| segmentation | GO:0035282 | 207 | 0.047 | |
| anterior posterior pattern specification | GO:0009952 | 136 | 0.047 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 3 | 0.047 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.046 | Human |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.046 | Human |
| regulation of cell differentiation | GO:0045595 | 302 | 0.045 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 106 | 0.045 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 79 | 0.044 | |
| chemotaxis | GO:0006935 | 249 | 0.043 | |
| organelle assembly | GO:0070925 | 198 | 0.043 | |
| organic acid metabolic process | GO:0006082 | 103 | 0.043 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.043 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.042 | |
| cellular response to organic cyclic compound | GO:0071407 | 32 | 0.042 | |
| dna metabolic process | GO:0006259 | 227 | 0.041 | Human |
| endomembrane system organization | GO:0010256 | 119 | 0.041 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.040 | Human |
| regulation of cell proliferation | GO:0042127 | 163 | 0.039 | |
| taxis | GO:0042330 | 304 | 0.038 | |
| eye development | GO:0001654 | 323 | 0.038 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.038 | |
| stem cell maintenance | GO:0019827 | 67 | 0.038 | |
| induction of programmed cell death | GO:0012502 | 12 | 0.036 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 78 | 0.035 | |
| negative regulation of cell differentiation | GO:0045596 | 143 | 0.035 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.034 | |
| rna processing | GO:0006396 | 147 | 0.034 | |
| growth | GO:0040007 | 359 | 0.033 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.033 | Human |
| negative regulation of transcription factor import into nucleus | GO:0042992 | 4 | 0.032 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.031 | |
| post embryonic appendage morphogenesis | GO:0035120 | 385 | 0.030 | |
| pole plasm assembly | GO:0007315 | 61 | 0.029 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.029 | |
| imaginal disc pattern formation | GO:0007447 | 91 | 0.029 | |
| compound eye photoreceptor cell differentiation | GO:0001751 | 140 | 0.029 | |
| axonogenesis | GO:0007409 | 290 | 0.029 | |
| muscle organ development | GO:0007517 | 127 | 0.029 | |
| determination of adult lifespan | GO:0008340 | 137 | 0.029 | |
| carboxylic acid metabolic process | GO:0019752 | 92 | 0.028 | |
| modification dependent protein catabolic process | GO:0019941 | 78 | 0.028 | |
| immune system development | GO:0002520 | 57 | 0.026 | |
| macromolecule methylation | GO:0043414 | 45 | 0.026 | Human |
| regulation of proteolysis | GO:0030162 | 87 | 0.025 | |
| regulation of mrna metabolic process | GO:1903311 | 72 | 0.025 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.025 | |
| morphogenesis of a branching structure | GO:0001763 | 45 | 0.024 | |
| germarium derived oocyte differentiation | GO:0030706 | 29 | 0.024 | |
| positive regulation of cell proliferation | GO:0008284 | 47 | 0.024 | |
| programmed cell death | GO:0012501 | 257 | 0.024 | |
| cellular ketone metabolic process | GO:0042180 | 24 | 0.024 | |
| covalent chromatin modification | GO:0016569 | 106 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 79 | 0.023 | |
| carbohydrate derivative catabolic process | GO:1901136 | 118 | 0.023 | |
| mitotic cell cycle checkpoint | GO:0007093 | 88 | 0.023 | |
| aging | GO:0007568 | 143 | 0.023 | |
| cell division | GO:0051301 | 248 | 0.023 | |
| chromatin modification | GO:0016568 | 147 | 0.023 | |
| camera type eye development | GO:0043010 | 4 | 0.022 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.022 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.022 | |
| respiratory system development | GO:0060541 | 213 | 0.022 | |
| cell maturation | GO:0048469 | 144 | 0.021 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.020 | Human |
| response to organic substance | GO:0010033 | 284 | 0.020 | |
| regulation of nuclear division | GO:0051783 | 58 | 0.020 | |
| female germ line cyst formation | GO:0048135 | 42 | 0.020 | |
| mrna metabolic process | GO:0016071 | 124 | 0.020 | |
| regulation of localization | GO:0032879 | 275 | 0.020 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 23 | 0.019 | |
| response to oxygen containing compound | GO:1901700 | 200 | 0.019 | |
| protein dna complex subunit organization | GO:0071824 | 86 | 0.019 | Human |
| negative regulation of gene expression epigenetic | GO:0045814 | 77 | 0.019 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.019 | |
| death | GO:0016265 | 284 | 0.019 | |
| macromolecule catabolic process | GO:0009057 | 161 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 85 | 0.019 | |
| cellular protein complex assembly | GO:0043623 | 71 | 0.018 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 64 | 0.018 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.018 | Human |
| oocyte microtubule cytoskeleton organization | GO:0016325 | 35 | 0.018 | |
| anatomical structure homeostasis | GO:0060249 | 97 | 0.018 | |
| embryonic pattern specification | GO:0009880 | 174 | 0.018 | |
| mrna splicing via spliceosome | GO:0000398 | 73 | 0.018 | |
| eye morphogenesis | GO:0048592 | 260 | 0.017 | |
| protein phosphorylation | GO:0006468 | 169 | 0.017 | |
| compound eye development | GO:0048749 | 307 | 0.017 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.017 | |
| male gamete generation | GO:0048232 | 201 | 0.017 | |
| pole plasm mrna localization | GO:0019094 | 49 | 0.017 | |
| morphogenesis of an epithelium | GO:0002009 | 276 | 0.016 | |
| regulation of gene silencing | GO:0060968 | 63 | 0.016 | |
| oxoacid metabolic process | GO:0043436 | 103 | 0.016 | |
| eggshell formation | GO:0030703 | 105 | 0.016 | |
| karyosome formation | GO:0030717 | 22 | 0.016 | |
| chromosome segregation | GO:0007059 | 157 | 0.016 | |
| genitalia development | GO:0048806 | 26 | 0.016 | |
| multi organism behavior | GO:0051705 | 175 | 0.015 | |
| response to oxidative stress | GO:0006979 | 86 | 0.015 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.015 | Human |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.015 | Human |
| positive regulation of cell cycle | GO:0045787 | 43 | 0.015 | |
| intracellular transport | GO:0046907 | 228 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 130 | 0.015 | |
| positive regulation of cell cycle process | GO:0090068 | 28 | 0.015 | |
| anterior posterior axis specification | GO:0009948 | 109 | 0.015 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 85 | 0.015 | |
| regulation of molecular function | GO:0065009 | 217 | 0.015 | |
| amine metabolic process | GO:0009308 | 12 | 0.015 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.015 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.015 | |
| epithelial cell differentiation | GO:0030855 | 322 | 0.014 | |
| feeding behavior | GO:0007631 | 50 | 0.014 | |
| positive regulation of organelle organization | GO:0010638 | 65 | 0.014 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.014 | Human |
| negative regulation of cell proliferation | GO:0008285 | 69 | 0.014 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.014 | |
| protein maturation | GO:0051604 | 71 | 0.014 | |
| developmental growth | GO:0048589 | 280 | 0.014 | |
| regulation of cellular catabolic process | GO:0031329 | 157 | 0.014 | |
| bmp signaling pathway | GO:0030509 | 27 | 0.014 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.014 | |
| brain development | GO:0007420 | 120 | 0.014 | |
| immune system process | GO:0002376 | 347 | 0.014 | |
| spermatogenesis | GO:0007283 | 200 | 0.013 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.013 | Human |
| locomotory behavior | GO:0007626 | 176 | 0.013 | |
| connective tissue development | GO:0061448 | 3 | 0.013 | |
| epithelial cell migration | GO:0010631 | 148 | 0.013 | |
| organelle localization | GO:0051640 | 148 | 0.013 | |
| single organism biosynthetic process | GO:0044711 | 206 | 0.013 | |
| regulation of translation | GO:0006417 | 56 | 0.013 | |
| ribonucleoprotein complex assembly | GO:0022618 | 23 | 0.013 | |
| pupal development | GO:0035209 | 11 | 0.013 | |
| regulation of cell death | GO:0010941 | 173 | 0.013 | |
| apoptotic process | GO:0006915 | 159 | 0.013 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.013 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.013 | |
| regulation of catabolic process | GO:0009894 | 170 | 0.013 | |
| ecdysone mediated induction of salivary gland cell autophagic cell death | GO:0035072 | 12 | 0.013 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.013 | |
| phosphorylation | GO:0016310 | 294 | 0.013 | |
| single organism behavior | GO:0044708 | 391 | 0.013 | |
| pole plasm oskar mrna localization | GO:0045451 | 46 | 0.012 | |
| anterior posterior axis specification embryo | GO:0008595 | 103 | 0.012 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.012 | |
| regulation of anatomical structure size | GO:0090066 | 163 | 0.012 | |
| positive regulation of signal transduction | GO:0009967 | 223 | 0.012 | |
| open tracheal system development | GO:0007424 | 204 | 0.012 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 44 | 0.012 | |
| telencephalon development | GO:0021537 | 2 | 0.012 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.012 | Human |
| forebrain development | GO:0030900 | 2 | 0.012 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 0 | 0.012 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.012 | Human |
| jak stat cascade | GO:0007259 | 49 | 0.012 | |
| regulation of programmed cell death | GO:0043067 | 152 | 0.012 | |
| response to ecdysone | GO:0035075 | 34 | 0.012 | |
| protein complex assembly | GO:0006461 | 200 | 0.012 | Human |
| cellular amine metabolic process | GO:0044106 | 12 | 0.012 | |
| cellular catabolic process | GO:0044248 | 372 | 0.012 | |
| protein acetylation | GO:0006473 | 39 | 0.012 | |
| protein processing | GO:0016485 | 68 | 0.012 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.012 | |
| spermatid differentiation | GO:0048515 | 114 | 0.012 | |
| cell fate specification | GO:0001708 | 71 | 0.011 | |
| peptidyl lysine modification | GO:0018205 | 57 | 0.011 | |
| rna localization | GO:0006403 | 115 | 0.011 | |
| reproductive structure development | GO:0048608 | 74 | 0.011 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 60 | 0.011 | |
| single organism cellular localization | GO:1902580 | 180 | 0.011 | |
| gland development | GO:0048732 | 191 | 0.011 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 57 | 0.011 | |
| protein polymerization | GO:0051258 | 42 | 0.011 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.011 | |
| heterochromatin organization involved in chromatin silencing | GO:0070868 | 9 | 0.011 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.011 | Human |
| germarium derived egg chamber formation | GO:0007293 | 101 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 85 | 0.011 | |
| response to alcohol | GO:0097305 | 95 | 0.011 | |
| autophagic cell death | GO:0048102 | 83 | 0.011 | |
| negative regulation of translation | GO:0017148 | 28 | 0.011 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 38 | 0.011 | |
| embryonic morphogenesis | GO:0048598 | 206 | 0.011 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.010 | Human |
| chromatin assembly or disassembly | GO:0006333 | 52 | 0.010 | |
| spindle assembly | GO:0051225 | 80 | 0.010 | |
| dna methylation or demethylation | GO:0044728 | 4 | 0.010 | Human |
| posttranscriptional gene silencing | GO:0016441 | 46 | 0.010 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.010 | |
| localization of cell | GO:0051674 | 257 | 0.010 | |
